{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:39:32Z","timestamp":1773373172770,"version":"3.50.1"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173173"],"award-info":[{"award-number":["82173173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    The dysregulation of N6-methyladenosine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) modification drives progression in non-small cell lung cancer (NSCLC), yet its interplay with traditional medicine-derived therapeutics remains largely unexplored. We propose a novel strategy that integrates m\n                    <jats:sup>6<\/jats:sup>\n                    A-based prognostic subtypes with Pueraria pharmacology to identify prognostic markers and therapeutic targets related to m\n                    <jats:sup>6<\/jats:sup>\n                    A regulators for NSCLC treatment. Multi-omics clustering of 1,661 NSCLC samples identified three distinct m\n                    <jats:sup>6<\/jats:sup>\n                    A modification patterns. Based on these, a robust 19-gene prognostic signature was constructed via Cox regression and validated in the GSE31210 dataset. This risk model significantly correlated with immune infiltration and patient survival. Furthermore, the expression patterns of these genes were validated via single-cell RNA-sequencing (scRNA-seq) and RT-qPCR in NSCLC cell lines. To identify pharmacological interventions, we intersected the m\n                    <jats:sup>6<\/jats:sup>\n                    A prognostic signature with 7,333 NSCLC-related genes and 366 Pueraria targets, revealing IGFBP1 as the core therapeutic nexus. Immunohistochemistry confirmed the expression of IGFBP1 in NSCLC tissues. Molecular docking and 100-ns molecular dynamics (MD) simulations confirmed stable binding of Pueraria compounds to IGFBP1, specifically 7,8,4\u2019-trihydroxyisoflavone (binding energy\u2009=\u2009-8.3 kcal\/mol) and genistein (-7.4 kcal\/mol). This study establishes IGFBP1 as a therapeutic nexus connecting m\n                    <jats:sup>6<\/jats:sup>\n                    A-driven NSCLC progression and the anti-tumor effects of Pueraria. Our RNA-modification-guided pharmacology approach advances the integration of traditional medicines into precision oncology.\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1014050","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:25:01Z","timestamp":1773336301000},"page":"e1014050","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-omics and network pharmacology identify IGFBP1 as an m6A-Epigenetic target of pueraria in NSCLC therapy"],"prefix":"10.1371","volume":"22","author":[{"given":"Rui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Mei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9538-7601","authenticated-orcid":true,"given":"Yi-Qing","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"3","key":"pcbi.1014050.ref001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"pcbi.1014050.ref002","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1097\/CM9.0000000000003268","article-title":"Global burden of lung cancer in 2022 and projected burden in 2050","volume":"137","author":"L Guo","year":"2024","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"pcbi.1014050.ref003","first-page":"193","article-title":"Understanding non-small-cell lung cancer: biology, therapeutics and drug resistance","volume":"14","author":"P Ahluwalia","year":"2026","journal-title":"Biomed"},{"key":"pcbi.1014050.ref004","article-title":"How long have I got? in stage IV NSCLC patients with at least 3 months up to 10 years survival, accuracy of long-, intermediate-, and short-term survival prediction is not good enough to answer this question","volume":"11","author":"H Guo","year":"2021","journal-title":"Front Oncol"},{"issue":"4","key":"pcbi.1014050.ref005","article-title":"Advances in detecting RNA modifications using direct RNA nanopore sequencing","volume":"6","author":"Y Liu","year":"2025","journal-title":"Adv Genet (Hoboken)"},{"issue":"12","key":"pcbi.1014050.ref006","first-page":"1888","article-title":"Advances in quantitative techniques for mapping RNA modifications","volume":"15","author":"L Tian","year":"2025","journal-title":"Life (Basel)"},{"issue":"1","key":"pcbi.1014050.ref007","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1038\/s41467-024-48437-4","article-title":"Transfer learning enables identification of multiple types of RNA modifications using nanopore direct RNA sequencing","volume":"15","author":"Y Wu","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"pcbi.1014050.ref008","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13578-024-01286-6","article-title":"Insights into the m6A demethylases FTO and ALKBH5\u00a0: structural, biological function, and inhibitor development","volume":"14","author":"Z Gao","year":"2024","journal-title":"Cell Biosci"},{"issue":"1","key":"pcbi.1014050.ref009","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-024-02089-6","article-title":"Writers, readers, and erasers RNA modifications and drug resistance in cancer","volume":"23","author":"D Chen","year":"2024","journal-title":"Mol Cancer"},{"issue":"5","key":"pcbi.1014050.ref010","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.7150\/thno.124482","article-title":"RNA Modifications in T Cell Immunity: Mechanisms, Disease Relevance, and Therapeutic Potential","volume":"16","author":"X Zhao","year":"2026","journal-title":"Theranostics"},{"issue":"8","key":"pcbi.1014050.ref011","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/genes16080951","article-title":"Uncovering the Epitranscriptome: A Review on mRNA Modifications and Emerging Frontiers","volume":"16","author":"DM Ruden","year":"2025","journal-title":"Genes (Basel)"},{"issue":"1","key":"pcbi.1014050.ref012","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1186\/s40001-025-03481-8","article-title":"Research progress on m6A RNA methylation modification in human reproduction related diseases","volume":"30","author":"X Sui","year":"2025","journal-title":"Eur J Med Res"},{"issue":"5","key":"pcbi.1014050.ref013","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/biom15050617","article-title":"The Role of N6-Methyladenosine (m6A) RNA Modification in the Pathogenesis of Parkinson\u2019s Disease","volume":"15","author":"Y Wang","year":"2025","journal-title":"Biomolecules"},{"key":"pcbi.1014050.ref014","doi-asserted-by":"crossref","first-page":"106008","DOI":"10.1016\/j.neuint.2025.106008","article-title":"Epitranscriptomic shifts in M6A RNA methylation influencing transcriptional dynamics in the prefrontal cortex of chronic restraint stress rats","volume":"188","author":"Y Funahashi","year":"2025","journal-title":"Neurochem Int"},{"issue":"9","key":"pcbi.1014050.ref015","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1111\/cas.16254","article-title":"Methyltransferase like-14 suppresses growth and metastasis of non-small-cell lung cancer by decreasing LINC02747","volume":"115","author":"J Wang","year":"2024","journal-title":"Cancer Sci"},{"issue":"1","key":"pcbi.1014050.ref016","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12967-023-04190-8","article-title":"HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p\/PTEN axis","volume":"21","author":"K Li","year":"2023","journal-title":"J Transl Med"},{"key":"pcbi.1014050.ref017","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.canlet.2021.07.022","article-title":"Cigarette smoking induces aberrant N6-methyladenosine of DAPK2 to promote non-small cell lung cancer progression by activating NF-\u03baB pathway","volume":"518","author":"M Jin","year":"2021","journal-title":"Cancer Lett"},{"key":"pcbi.1014050.ref018","doi-asserted-by":"crossref","first-page":"1087753","DOI":"10.3389\/fonc.2022.1087753","article-title":"m6A regulators featured by tumor immune microenvironment landscapes and correlated with immunotherapy in non-small cell lung cancer (NSCLC)","volume":"12","author":"B Yuan","year":"2022","journal-title":"Front Oncol"},{"key":"pcbi.1014050.ref019","article-title":"Identification of a novel m5C\/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma","volume":"13","author":"Y Ma","year":"2022","journal-title":"Front Genetics"},{"issue":"1","key":"pcbi.1014050.ref020","doi-asserted-by":"crossref","first-page":"2190618","DOI":"10.1080\/07853890.2023.2190618","article-title":"RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer","volume":"55","author":"Y Wang","year":"2023","journal-title":"Ann Med"},{"issue":"4","key":"pcbi.1014050.ref021","first-page":"1068","article-title":"The roles and mechanisms of YTH domain-containing proteins in cancer development and progression","volume":"10","author":"S Liu","year":"2020","journal-title":"Am J Cancer Res"},{"key":"pcbi.1014050.ref022","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3389\/fcell.2020.00642","article-title":"N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients","volume":"8","author":"Z Tu","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"pcbi.1014050.ref023","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.7150\/thno.92336","article-title":"Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression","volume":"14","author":"T Zhang","year":"2024","journal-title":"Theranostics"},{"issue":"11","key":"pcbi.1014050.ref024","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/s12276-022-00896-9","article-title":"Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics","volume":"54","author":"J Zhu","year":"2022","journal-title":"Exp Mol Med"},{"issue":"1","key":"pcbi.1014050.ref025","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1038\/s41598-025-34150-9","article-title":"Network pharmacology and molecular docking reveal mechanisms of amiodarone-induced pulmonary fibrosis","volume":"16","author":"H Li","year":"2026","journal-title":"Sci Rep"},{"issue":"1","key":"pcbi.1014050.ref026","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1038\/s41598-024-58877-z","article-title":"Network pharmacology combined with molecular docking and experimental verification to elucidate the effect of flavan-3-ols and aromatic resin on anxiety","volume":"14","author":"A Vikhar Danish Ahmad","year":"2024","journal-title":"Sci Rep"},{"issue":"1384","key":"pcbi.1014050.ref027","article-title":"Integrative network pharmacology and molecular docking approaches in herbal medicine research: a systematic review of applications, advances, and translational potential","volume":"14","author":"DT Swase","year":"2025","journal-title":"F1000 Res"},{"key":"pcbi.1014050.ref028","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.2147\/DDDT.S553875","article-title":"Integrating Network Pharmacology and Experimental Validation to Investigate the Action Mechanism of Allicin in Atherosclerosis","volume":"19","author":"S Wu","year":"2025","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"pcbi.1014050.ref029","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13578-025-01368-z","article-title":"The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes","volume":"15","author":"T Shi","year":"2025","journal-title":"Cell Biosci"},{"key":"pcbi.1014050.ref030","doi-asserted-by":"crossref","first-page":"1692608","DOI":"10.3389\/fimmu.2025.1692608","article-title":"Decoding m6A readers: roles of YTHDF proteins in leukemogenesis and cancer immunity","volume":"16","author":"C Li","year":"2025","journal-title":"Front Immunol"},{"issue":"14","key":"pcbi.1014050.ref031","article-title":"Consensus clustering and novel risk score model construction based on m6A methylation regulators to evaluate the prognosis and tumor immune microenvironment of early-stage lung adenocarcinoma","volume":"16","author":"MYZ He","year":"2024","journal-title":"Aging"},{"issue":"9","key":"pcbi.1014050.ref032","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.7150\/ijbs.94339","article-title":"Cigarette smoke promotes IL-6-dependent lung cancer migration and osteolytic bone metastasis","volume":"20","author":"J-H Guo","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"22","key":"pcbi.1014050.ref033","article-title":"Smoking-Induced M2-TAMs, via circEML4 in EVs, Promote the Progression of NSCLC through ALKBH5-Regulated m6A Modification of SOCS2 in NSCLC Cells","volume":"10","author":"C Cheng","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"pcbi.1014050.ref034","doi-asserted-by":"crossref","first-page":"1697560","DOI":"10.3389\/fimmu.2025.1697560","article-title":"Multi-omics integration and machine learning identify NPC2 as a prognostic and treatment-responsive regulator in lung adenocarcinoma","volume":"16","author":"A Li","year":"2026","journal-title":"Front Immunol"},{"issue":"1","key":"pcbi.1014050.ref035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-025-08355-9","article-title":"Non-canonical NOTCH1 signaling regulates ferroptosis vulnerability in dormant lung cancer cells with stable resistance","volume":"17","author":"H Huang","year":"2025","journal-title":"Cell Death Dis"},{"issue":"1","key":"pcbi.1014050.ref036","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12935-025-03764-4","article-title":"A novel mitochondrial quality regulation gene signature for anticipating prognosis, TME, and therapeutic response in LUAD by multi-omics analysis and experimental verification","volume":"25","author":"L Zeng","year":"2025","journal-title":"Cancer Cell Int"},{"issue":"1","key":"pcbi.1014050.ref037","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-025-02524-2","article-title":"Development and validation of a small extracellular vesicle-derived RNA signature for early diagnosis of lung adenocarcinoma and prognosis in advanced stages","volume":"25","author":"R Meng","year":"2025","journal-title":"Mol Cancer"},{"key":"pcbi.1014050.ref038","doi-asserted-by":"crossref","first-page":"1735459","DOI":"10.3389\/fimmu.2025.1735459","article-title":"Single-cell RNA sequencing reveals heterogeneity among AT2 epithelial cells in the lung adenocarcinoma microenvironment","volume":"16","author":"Z Cao","year":"2025","journal-title":"Front Immunol"},{"issue":"1","key":"pcbi.1014050.ref039","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13046-024-03073-0","article-title":"ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages","volume":"43","author":"X Hua","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"pcbi.1014050.ref040","article-title":"Crosstalk of RNA adenosine modification-related subtypes, establishment of a prognostic model, and immune infiltration characteristics in ovarian cancer","volume":"13","author":"X Ni","year":"2022","journal-title":"Front Immunol"},{"key":"pcbi.1014050.ref041","doi-asserted-by":"crossref","first-page":"104268","DOI":"10.1016\/j.ebiom.2022.104268","article-title":"RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer","volume":"84","author":"B Zhou","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"pcbi.1014050.ref042","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s12672-026-04600-5","article-title":"Multiomics analysis identifies the prognostic significance and biological roles of the HNRNP family in lung adenocarcinoma","volume":"17","author":"J Li","year":"2026","journal-title":"Discov Oncol"},{"issue":"2","key":"pcbi.1014050.ref043","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00116-21","article-title":"Enterovirus 2Apro cleavage of the YTHDF m6A readers implicates YTHDF3 as a mediator of type I interferon-driven JAK\/STAT signaling","volume":"12","author":"JP Kastan","year":"2021","journal-title":"mBio"},{"issue":"3","key":"pcbi.1014050.ref044","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2023.01.006","article-title":"RNA m6A methylation across the transcriptome","volume":"83","author":"E Sendinc","year":"2023","journal-title":"Mol Cell"},{"issue":"1","key":"pcbi.1014050.ref045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-021-01447-y","article-title":"METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer","volume":"21","author":"W Wan","year":"2022","journal-title":"Mol Cancer"},{"issue":"1","key":"pcbi.1014050.ref046","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1186\/s12967-023-04651-0","article-title":"Role of m6A modification in regulating the PI3K\/AKT signaling pathway in cancer","volume":"21","author":"J Liu","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"pcbi.1014050.ref047","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12935-025-04026-z","article-title":"Unveiling the role of m6A modification in esophageal cancer: a new frontier in tumor innate interferon immunity","volume":"25","author":"X Zuo","year":"2025","journal-title":"Cancer Cell Int"},{"issue":"1","key":"pcbi.1014050.ref048","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"B Wu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"pcbi.1014050.ref049","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12935-024-03307-3","article-title":"Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma","volume":"24","author":"Y Shi","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"6","key":"pcbi.1014050.ref050","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3892\/ol.2025.15350","article-title":"m6A RNA methylation regulator-associated genes drive metastasis and immune cell infiltration in skin cutaneous melanoma","volume":"30","author":"Y Geng","year":"2025","journal-title":"Oncol Lett"},{"issue":"1","key":"pcbi.1014050.ref051","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41419-025-08155-1","article-title":"IGF2BP3 regulates EMP1 stability in an m6A-dependent manner and activates the TGF-\u03b2 pathway to promote pancreatic cancer invasion","volume":"16","author":"L Liu","year":"2025","journal-title":"Cell Death Dis"},{"issue":"11","key":"pcbi.1014050.ref052","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.21037\/tcr-2025-aw-2305","article-title":"Prognostic potential of N6-methyladenosine methylation-associated genes in lung adenocarcinoma","volume":"14","author":"Y Lei","year":"2025","journal-title":"Transl Cancer Res"},{"issue":"6","key":"pcbi.1014050.ref053","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3892\/ol.2025.15333","article-title":"Prognostic role and mutational characteristics of N6-methyladenosine-related genes in lung adenocarcinoma","volume":"30","author":"J Yang","year":"2025","journal-title":"Oncol Lett"},{"issue":"16","key":"pcbi.1014050.ref054","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.7150\/ijms.119651","article-title":"Comprehensive analysis of aberrant m6A RNA modifications identifies prognostic biomarkers in non-small cell lung cancer","volume":"22","author":"Y Li","year":"2025","journal-title":"Int J Med Sci"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:25:14Z","timestamp":1773336314000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014050"}},"subtitle":[],"editor":[{"given":"Shaun","family":"Mahony","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1014050","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}